• No results found

[PDF] Top 20 Poster Session 7: Prostate Cancer (2)

Has 10000 "Poster Session 7: Prostate Cancer (2)" found on our website. Below are the top 20 most common "Poster Session 7: Prostate Cancer (2)".

Poster Session 7: Prostate Cancer (2)

Poster Session 7: Prostate Cancer (2)

... (24%), prostate cancer specific (21%) and physical and daily living ...the cancer is under control (37%), being treated as a person (34%), being informed about benefits and side effects of treatments ... See full document

12

Moderated Poster Session 6: Oncology: Kidney, Prostate and Testis

Moderated Poster Session 6: Oncology: Kidney, Prostate and Testis

... and IORT for locally advanced prostate cancer. Inclusion criteria were: age younger than 75 years, clinical stage T3-T4, N0–1, M0, probability of extracapsular disease greater than 25% (according to Kattan ... See full document

5

Poster Session 7: Voiding Dysfunction

Poster Session 7: Voiding Dysfunction

... large prostate ≥120cc (PV120) or with indwelling catheter for urinar ...the prostate for the treatment of BPH performed at 6 international ...Warfarin. Prostate size ≥120cc subgroup was defined by ... See full document

13

Poster Session 4: Kidney Cancer

Poster Session 4: Kidney Cancer

... Methods: We retrospectively reviewed all patients undergoing radical and partial nephrectomies between January 1, 2011 and June 30, 2014 for cT1 renal masses. All pre-operative imaging scans were reviewed and the ... See full document

11

Moderated Poster Session V: Oncology 2

Moderated Poster Session V: Oncology 2

... Improved prostate cancer (CaP) detection using targeted Magnetic Resonance Imaging-Ultrasound (MRI-US) fusion compared to conventional biopsy has been shown in patients with repeat prostate ...fusion ... See full document

6

Poster Session 8: Bladder Cancer

Poster Session 8: Bladder Cancer

... Methods: From our institutional pilot prospective inter-disciplinary study of complications after RC, 104 pt undergoing RC between January 2011and November 2014 were evaluated before surgery by a physio- therapist using ... See full document

8

Moderated Poster Session 2: Kidney Cancer

Moderated Poster Session 2: Kidney Cancer

... These cancer-specific differences in survival persisted throughout individual pathologic stages, with the exception of pathologic stage pT4 and metastatic ... See full document

6

Moderated Poster Session 8: Kidney Cancer

Moderated Poster Session 8: Kidney Cancer

... Materials and Methods: We searched MEDLINE for all relevant articles published up to July 31, 2008. We included all randomized-controlled trials (RCTs), cohort studies, and case-based studies that were published in ... See full document

5

Moderated Poster Session III: Oncology 1

Moderated Poster Session III: Oncology 1

... castration-resistant prostate cancer who have progressed on luteinizing hormone-releasing hormone agonist/antagonist therapy or after bilateral orchiectomy, while maintaining castration therapy during the ... See full document

7

Poster Session 11: Urologic Malignancies (2)

Poster Session 11: Urologic Malignancies (2)

... Results: Overall, 33/98 (33.7%) of reviews had significant changes associ- ated with management implications, mainly due to changes in risk category. On review, 12 patients were recommended radical cystectomy instead of ... See full document

7

Moderated Poster Session I: Oncology

Moderated Poster Session I: Oncology

... TRUS prostate biopsy between July 2012 and December ...larger prostate volume, greater number of biopsies during the procedure, and cancer in remission; other baseline demographics were ...for ... See full document

6

Poster Session 3: Basic Science

Poster Session 3: Basic Science

... osteolytic prostate cancer (PCa) bone ...human prostate cancer tissue, we accessed the Canadian Prostate Cancer Biomarker Network tissue microarray test series composed of ... See full document

7

Poster Session 8: Functional Urology

Poster Session 8: Functional Urology

... International Prostate Symptom Score (IPSS) 24/35 ...the prostate (TURP), four patients sought medical care for hematuria, three patients required dilation for urethral or bladder neck stricture, one ... See full document

11

Moderated Poster Session 6: Oncology

Moderated Poster Session 6: Oncology

... Introduction and Objective: Several studies have examined the rela- tionship between insulin-like growth factor I (IGF-I), and its binding pro- teins 2 (IGFBP-2) and 3 (IGFBP-3) with prostate cancer risk. A ... See full document

6

Poster Session 6: Prostate (II)

Poster Session 6: Prostate (II)

... underwent prostate biopsy performed by the same urologist at the Centre Hospitalier Universitaire de Québec between September 2011 and June ...high-risk cancer (Gleason ≥7) between these two ... See full document

15

Moderated Poster Session 1: Prostate Cancer

Moderated Poster Session 1: Prostate Cancer

... developed prostate cancer and were treat- ed with radical radiation therapy using IMRT technique delivered via Helical Tomotherapy ...the prostate, with or without the proximal seminal vesicles, ... See full document

5

Moderated Poster Session 4: Prostate and Testes Cancer

Moderated Poster Session 4: Prostate and Testes Cancer

... Results: Of all patients, 99 (9.9%) had METS. The actuarial METS-free survival for all 1004 men was 81% (95% confidence interval [CI], 78- 84%) 20 years after surgery. Median time to METS after surgery was not reached ... See full document

5

Poster Session 1: Prostate (I)

Poster Session 1: Prostate (I)

... localized prostate cancer scheduled for RARP are consecutively recruited in clinic and randomly allocated to either the Rocco stitch or conventional anastomosis ... See full document

10

Poster Session 1: Prostate Cancer (1)

Poster Session 1: Prostate Cancer (1)

... localized prostate cancer (HR-CLPC) at initial ...examine cancer control and perioperative outcomes in men who underwent RARP for ...HR-CLPC. Cancer control outcomes were biochemical ... See full document

18

Poster Session 4: Urologic Malignancies (1)

Poster Session 4: Urologic Malignancies (1)

... disseminated cancer, pre-operative weight loss >10% in the previous 6 months, smoking, low serum albumin concentration, pre-operative che- motherapy, and longer operating times ... See full document

8

Show all 10000 documents...

Related subjects